首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Clinical efficacy of treatment for primary tracheal tumors by flexible bronchoscopy: Airway stenosis recanalization and quality of life
【2h】

Clinical efficacy of treatment for primary tracheal tumors by flexible bronchoscopy: Airway stenosis recanalization and quality of life

机译:柔性支气管镜检查治疗原发性气管肿瘤的临床疗效:气道狭窄重新分析和生活质量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to evaluate the effectiveness of interventional treatment of primary tracheal tumors through flexible bronchoscopy. The clinical data of 38 patients with primary tracheal tumours who underwent flexible bronchoscopy intervention therapy between January 2011 and January 2017 were retrospectively analyzed. The average time interval from onset of symptoms to the appearance of actual clinical manifestations in the 38 patients ranged from 0 to 60 months, with an average of 8.1±11.6 months and a median of 4.2 months. The rate of misdiagnosis at the first visit was 36.8% (14/38). After interventional treatment, the overall efficiency (complete + partial response) of airway stenosis recanalization in the 38 patients was 89.5%. In 3 patients with benign tumors, the anhelation score was reduced following treatment (1.00±0.77 vs. 3.13±1.21 at the pre-treatment stage; P<0.001). The overall survival rates of the 35 patients at 1, 3 and 5 years were 69.3, 48.7 and 20.3%, respectively. Therefore, flexible bronchoscopic intervention may effectively smoothen the airways of patients and relieve the symptoms of anhelation. Combining radiotherapy and chemotherapy may improve patient prognosis and safety.
机译:本研究的目的是通过柔性支气管镜来评估主气管肿瘤介入治疗的有效性。 38例谁接受2011年1月和一月至2017年间纤维支气管镜介入治疗原发性气管肿瘤的临床资料进行回顾性分析。从症状发作到实际临床表现的在38名患者的外观的平均时间间隔从0至60个月〜,平均的8.1±11.6个月和4.2个月的中间。误诊的第一次访问率为36.8%(14/38)。介入治疗之后,在38名患者的气道狭窄的血管再通的总效率(完全+部分响应)为89.5%。在3例良性肿瘤,气促评分减少以下处理(1.00±0.77对3.13±1.21,在预处理阶段; P <0.001)。在1,3年和5年的35例患者的总生存率分别为69.3,48.7和20.3%,分别。因此,灵活的支气管镜介入可以有效抚平患者的气道,缓解气促的症状。结合放疗和化疗可改善患者的预后和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号